SAN FRANCISCO, CA—A novel method of delivering drug therapy via ultrasound assistance appears effective in reversing right ventricular enlargement and dysfunction in patients with submassive pulmonary ...

An ultrasound-assisted thrombolysis strategy is more effective than heparin alone for reversing right ventricle dilation in patients with acute, intermediate-risk pulmonary embolism and is not ...

Clinical trials ULTIMA was the first prospective, multicenter study to investigate whether UFH with adjunctive fixed-dose USCDT was superior to UFH alone. Fifty-nine patients with submassive PE ...

When administered in hemodynamically stable patients with right ventricular dysfunction due to acute pulmonary embolism (submassive pulmonary embolism), fibrinolytic therapy has been shown to ...

The study concluded that treatment with ultrasound-facilitated catheter-directed low-dose thrombolysis for acute pulmonary embolism (PE) improves right heart function, reduces blood clot size, and ...

A retrospective comparative case series of 25 patients with acute massive pulmonary embolism (PE) compared ultrasound‑enhanced, catheter‑directed thrombolysis (UE‑CDT; n=11) against catheter-directed ...

Carried out in collaboration with the Pulmonary Embolism Response Team (PERT) Consortium, the trial enrolled 100 subjects. It aims to offer evidence on the role of CAVT in improving right heart ...

Lubarsch, 14 in 1918, observed pulmonary embolism in 18 per cent of his autopsies; Møller 15 had brought this up to 28 per cent by 1923, and Schoenmackers 16 to 39 per cent by 1958.

If you experience right ventricular heart failure, the risk of death within 24 hours is two to three times higher than acute pulmonary embolism without RHT. According to a 2013 review of research ...